[go: up one dir, main page]

NO810034L - Hybrid cellelinje for fremstilling av monoklonalt antistoff til et t-celleantigen hos mennesker, samt antistoff - Google Patents

Hybrid cellelinje for fremstilling av monoklonalt antistoff til et t-celleantigen hos mennesker, samt antistoff

Info

Publication number
NO810034L
NO810034L NO810034A NO810034A NO810034L NO 810034 L NO810034 L NO 810034L NO 810034 A NO810034 A NO 810034A NO 810034 A NO810034 A NO 810034A NO 810034 L NO810034 L NO 810034L
Authority
NO
Norway
Prior art keywords
antibody
monoclonal antibody
human
cell line
hybrid
Prior art date
Application number
NO810034A
Other languages
English (en)
Other versions
NO159621C (no
NO159621B (no
Inventor
Patrick Chung-Shu Kung
Gideon Goldstein
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22333406&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO810034(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO810034L publication Critical patent/NO810034L/no
Publication of NO159621B publication Critical patent/NO159621B/no
Publication of NO159621C publication Critical patent/NO159621C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2806—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Microwave Amplifiers (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
NO810034A 1980-01-08 1981-01-07 Monoklonalt antistoff. NO159621C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/110,510 US4364937A (en) 1980-01-08 1980-01-08 Monoclonal antibody to a human T cell antigen and methods of preparing same

Publications (3)

Publication Number Publication Date
NO810034L true NO810034L (no) 1981-07-09
NO159621B NO159621B (no) 1988-10-10
NO159621C NO159621C (no) 1989-01-18

Family

ID=22333406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810034A NO159621C (no) 1980-01-08 1981-01-07 Monoklonalt antistoff.

Country Status (22)

Country Link
US (1) US4364937A (no)
EP (1) EP0033578B1 (no)
JP (2) JPS56103115A (no)
AT (1) ATE13198T1 (no)
AU (1) AU545225B2 (no)
CA (1) CA1171006A (no)
DE (2) DE33578T1 (no)
DK (1) DK154092C (no)
ES (1) ES8303098A1 (no)
FI (1) FI75184C (no)
GR (1) GR72758B (no)
HK (1) HK24486A (no)
IE (1) IE50801B1 (no)
IL (1) IL61876A (no)
MY (1) MY8700060A (no)
NO (1) NO159621C (no)
NZ (1) NZ195939A (no)
PH (2) PH20275A (no)
PT (1) PT72312B (no)
SG (1) SG7286G (no)
YU (1) YU45069B (no)
ZA (1) ZA8199B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614720A (en) * 1980-01-08 1986-09-30 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human T cell antigen, antibody, and methods
US4743681A (en) * 1980-01-08 1988-05-10 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human T cell antigen, antibody, and methods
US4582797A (en) * 1980-09-25 1986-04-15 The Salk Institute For Biological Studies Monoclonal antibodies specific for human hematopoietic cell surface glycoproteins
US4434156A (en) 1981-10-26 1984-02-28 The Salk Institute For Biological Studies Monoclonal antibodies specific for the human transferrin receptor glycoprotein
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4950598A (en) * 1982-09-22 1990-08-21 The Board Of Trustees Of The Leland Stanford Junior University Process for making T cell hybridomas
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US5362854A (en) * 1983-03-31 1994-11-08 Scripps Clinic & Research Foundation Factor VIII coagulant polypeptides: method of making
CA1341506C (en) * 1983-03-31 2006-06-06 Theodore S. Zimmerman Factor viii coagulant polypeptides and monoclonal antibodies to them
US4645738A (en) * 1983-09-30 1987-02-24 Memorial Sloan-Kettering Institute Cancer Center Method for differential diagnosis of T cell leukemias using monoclonal antibodies
JPS60231699A (ja) * 1983-11-09 1985-11-18 Aichiken 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体
US5130144B1 (en) * 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
US4965204A (en) * 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4649106A (en) * 1984-06-01 1987-03-10 Dana-Farber Cancer Institute, Inc. Distinguishing subsets of human cells
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
US4886743A (en) * 1985-04-24 1989-12-12 California Institute Of Technology Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof
AU6032786A (en) * 1985-07-25 1987-01-29 University Of Minnesota Detection, imaging and therapy of renal cell carcinoma with monoclonal antibodies in vivo
GB8605316D0 (en) * 1986-03-04 1986-04-09 Royal Free Hosp School Med Immunosuppression
US5466585A (en) * 1986-04-15 1995-11-14 Ciba-Geigy Corporation Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies
US6407209B1 (en) 1986-04-15 2002-06-18 Novartis Ag Interferon-induced human protein in pure form, monoclonal antibodies thereto and test kits containing these antibodies
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US4882424A (en) * 1987-05-11 1989-11-21 Dana-Farber Cancer Institute, Inc. Activation antigen
JP2530210B2 (ja) * 1988-07-29 1996-09-04 株式会社日本抗体研究所 臓器移殖による異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
JPH02137655U (no) * 1989-04-20 1990-11-16
US5118618A (en) * 1989-10-05 1992-06-02 Foodscience Corporation Dimethylglycine enhancement of antibody production
US6498006B2 (en) 1997-11-24 2002-12-24 Johnson T. Wong Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy
US7653260B2 (en) 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system
RU2264826C1 (ru) * 2004-12-30 2005-11-27 Голубева Вера Леонидовна Способ получения антитимоцитарного глобулина для внутривенного введения

Also Published As

Publication number Publication date
JPH0159871B2 (no) 1989-12-20
DK154092C (da) 1989-05-22
EP0033578B1 (en) 1985-05-08
GR72758B (no) 1983-12-02
YU327580A (en) 1985-03-20
HK24486A (en) 1986-04-11
EP0033578A3 (en) 1981-12-30
PT72312B (en) 1982-07-23
JPS645040B2 (no) 1989-01-27
DE3170352D1 (en) 1985-06-13
FI810026L (fi) 1981-07-09
IL61876A0 (en) 1981-02-27
AU545225B2 (en) 1985-07-04
DK154092B (da) 1988-10-10
ATE13198T1 (de) 1985-05-15
EP0033578A2 (en) 1981-08-12
DK5381A (da) 1981-07-09
FI75184B (fi) 1988-01-29
CA1171006A (en) 1984-07-17
IL61876A (en) 1984-07-31
NO159621C (no) 1989-01-18
JPS56103115A (en) 1981-08-18
ES498360A0 (es) 1982-12-16
PH20552A (en) 1987-02-09
PH20275A (en) 1986-11-14
IE50801B1 (en) 1986-07-23
ZA8199B (en) 1982-08-25
FI75184C (fi) 1988-05-09
PT72312A (en) 1981-02-01
IE810018L (en) 1981-07-08
JPS6413989A (en) 1989-01-18
DE33578T1 (de) 1984-08-02
YU45069B (en) 1991-08-31
US4364937A (en) 1982-12-21
SG7286G (en) 1986-08-01
MY8700060A (en) 1987-12-31
NZ195939A (en) 1984-07-06
ES8303098A1 (es) 1983-02-16
NO159621B (no) 1988-10-10
AU6600181A (en) 1981-07-16

Similar Documents

Publication Publication Date Title
NO810034L (no) Hybrid cellelinje for fremstilling av monoklonalt antistoff til et t-celleantigen hos mennesker, samt antistoff
NO803661L (no) Hybridcellelinje for fremstilling av monoklonalt antistoff til et humant prothymocyttantigen
DK154087C (da) Monoklonalt antistof, fremstilling heraf, hybrodimacellelinie til anvendelse ved fremstilling heraf, fremgangsmaade til anvendelse heraf samt diagnostisk praeparat indeholdende antistoffet
ES497422A0 (es) Un metodo de preparacion de un inticuerpo monocloral.
NO810035L (no) Hybrid cellelinje for fremstilling av monoklonalt antistoff til et monocytt-antigen hos mennesker, samt antistoff
NO803660L (no) Hybridcellelinje for fremstilling av monoklonalt antistoff til et antigen.
ES497423A0 (es) Un anticuerpo monoclonico

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JANUARY 2001

MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2001